Reversible host cell surface remodelling limits immune recognition and maximizes survival of Plasmodium falciparum gametocytes
Ngotho P. et al, (2025), PLOS PATHOGENS, 21
Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.
Kinyua AW. et al, (2024), The Journal of infection, 89
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life science alliance, 7
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Social, Ethical and Regulatory implications of conducting a malaria Vaccine Efficacy trial in a human infection study in Kenya (SERVE-Kenya): A study protocol
Chi PC. et al, (2024), Wellcome Open Research, 9, 193 - 193
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.
Kapulu MC. et al, (2024), Frontiers in immunology, 15
The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study.
Kariuki SN. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera DO. et al, (2023), Science translational medicine, 15
Sporozoite immunization: innovative translational science to support the fight against malaria.
Richie TL. et al, (2023), Expert review of vaccines, 22, 964 - 1007
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
Kapulu MC. et al, (2022), BMC Infectious Diseases, 22
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
Musasia FK. et al, (2022), Nature communications, 13
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Williams E. et al, (2022), Vaccine, 40, 3484 - 3489
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.
Chi PC. et al, (2022), BMC medical ethics, 23
Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.
Kimingi HW. et al, (2022), Frontiers in immunology, 13
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.
Kapulu MC. et al, (2022), Frontiers in immunology, 13
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.
Mumba N. et al, (2022), Frontiers in public health, 10
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia
Kunda-Ng'andu EM. et al, (2021), Wellcome Open Research, 6, 31 - 31